Učitavanje...
Antiplatelet Therapy Improves the Prognosis of Patients with Hepatocellular Carcinoma
SIMPLE SUMMARY: Antiplatelet therapy shows antitumor effect in several types of cancers. In liver disease, antiplatelet therapy reduces liver fibrosis and occurrence of HCC. However, the effect after diagnosis of hepatocellular carcinoma is still unknown. Therefore, we aimed to clarify the effects o...
Spremljeno u:
| Izdano u: | Cancers (Basel) |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7693153/ https://ncbi.nlm.nih.gov/pubmed/33142758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12113215 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|